Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults

Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes

(2018) George Hindy et al.   STROKE

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

(2018) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke

(2017) Jemma C Hopewell et al.   EUROPEAN HEART JOURNAL

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013

(2016) Maigeng Zhou et al.   LANCET

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

(2016) Emanuele Di Angelantonio et al.   LANCET

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

(2016) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

(2016) Brian A. Ference et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China

(2016) Sarah Lewington et al.   JAMA Internal Medicine

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

(2015)   LANCET

Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality

(2015) Gregory A. Roth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

(2015) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

LDL cholesterol: controversies and future therapeutic directions

(2014) Paul M Ridker   LANCET

Common variants associated with plasma triglycerides and risk for coronary artery disease

(2013) Ron Do et al.   NATURE GENETICS

Discovery and refinement of loci associated with lipid levels

(2013) Cristen J Willer et al.   NATURE GENETICS

Epidemiology of stroke and its subtypes in Chinese vs white populations: A systematic review

(2013) C.-F. Tsai et al.   NEUROLOGY

Instrumental Variable Estimation of Causal Risk Ratios and Causal Odds Ratios in Mendelian Randomization Analyses

(2011) T. M. Palmer et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care

(2011) R Peto   BRITISH JOURNAL OF CANCER

China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up

(2011) Z. Chen et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

(2011) Colin Baigent et al.   LANCET

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

(2008) Anne B. Rossebø et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiological Transition of Stroke in China

(2008) Dong Zhao et al.   STROKE